Location History:
- Poznan, PL (2017)
- Cracow, PL (2020)
Company Filing History:
2 out of 5 
1 out of 4 Years Active: 2017-2020
Title: **Agnieszka Dreas: Innovator in Kinase Inhibition**
Introduction
Agnieszka Dreas is a prominent inventor based in Cracow, Poland, known for her significant contributions to the field of medicinal chemistry. Specializing in innovative compounds that target specific kinases, she has developed groundbreaking inventions that offer promising therapeutic avenues for various diseases.
Latest Patents
Agnieszka Dreas holds two notable patents that showcase her expertise in developing kinase inhibitors. The first patent, titled "Derivatives of Quinoline as Inhibitors of DYRK1A and/or DYRK1B Kinases," details a compound that functions as a medicament, including various forms such as salts, stereoisomers, tautomers, and N-oxides. This compound aims to provide therapeutic benefits through its inhibition of specified kinase activity.
Her second patent focuses on "Substituted Tricyclic Benzimidazoles as Kinase Inhibitors." This invention outlines compounds that selectively inhibit CDK8, proving beneficial for treating colorectal and melanoma cancers, along with other solid and hematological malignancies, autoimmune diseases, and inflammatory disorders. The patent also includes methodologies for synthesizing these innovative compounds, underscoring her role as a leader in the development of effective treatments.
Career Highlights
Agnieszka has made impressive strides in her career, with valuable experience gained from her roles at esteemed companies such as Selvita S.A. and Felicitex Therapeutics, Inc. These organizations have supported her in advancing her research and patent efforts, positioning her as a key figure in the field of pharmaceutical innovation.
Collaborations
Throughout her career, Agnieszka Dreas has collaborated with notable professionals, including Michal Galezowski and Wojciech Czardybon. These partnerships have fostered an environment of innovation and creativity, driving the development of her patented compounds and expanding the potential for collaborative advancements in health-related technologies.
Conclusion
Agnieszka Dreas's contributions to the field of medicinal chemistry and her innovative patents reflect her dedication to improving therapeutic options for serious health conditions. Her work not only showcases her skill as an inventor but also highlights the impact of collaborative efforts in the pursuit of groundbreaking solutions in medicine.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.